Rxo (RXO) Invested Capital (2021 - 2026)

Rxo (RXO) has reported Invested Capital for 6 consecutive years, with $2.0 billion the latest figure, recorded in Q1 2026.

• Invested Capital for Q1 2026 came in at $2.0 billion, down 1.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.0 billion (down 1.76% YoY), and the FY2025 annual result was $1.9 billion, down 1.77% from the prior year.
• Invested Capital was $2.0 billion for Q1 2026 at Rxo, up from $1.9 billion in the prior quarter.
• Over five years, Invested Capital peaked at $2.0 billion in Q3 2024 and troughed at $949.0 million in Q1 2024.
• Average Invested Capital over 5 years is $1.4 billion, with a median of $1.1 billion recorded in 2022.
• Year-over-year, Invested Capital retreated 12.93% in 2023 and surged 109.8% in 2025.
• Over 5 years, Invested Capital stood at $1.0 billion in 2022, then retreated by 8.54% to $953.0 million in 2023, then surged by 107.76% to $2.0 billion in 2024, then fell by 1.77% to $1.9 billion in 2025, then grew by 0.57% to $2.0 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $2.0 billion in Q1 2026, $1.9 billion in Q4 2025, and $2.0 billion in Q3 2025.